Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (32)

Search Parameters:
Authors = Giorgio Lo Giudice ORCID = 0000-0001-9944-1073

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
22 pages, 1027 KiB  
Article
Mental Illness Strikes at the Heart: Impact of Psychiatric Diseases on Ventricular Ejection Fraction in Patients with Acute Coronary Syndromes
by Marianna Mazza, Giorgio Veneziani, Francesco Maria Lisci, Sofia Morini, Gianandrea Traversi, Greta Sfratta, Caterina Brisi, Maria Benedetta Anesini, Francesca Bardi, Elisabetta Benini, Claudia Calderoni, Luca Chisari, Arianna Crupi, Emanuela De Chiara, Luca Lo Giudice, Luca Onori, Ilenia Sessa, Marta Balocchi, Roberto Pola, Eleonora Gaetani, Benedetta Simeoni, Francesco Franceschi, Gabriele Sani, Marcello Covino, Carlo Lai, Enrico Romagnoli and Giuseppe Maranoadd Show full author list remove Hide full author list
Life 2025, 15(3), 340; https://doi.org/10.3390/life15030340 - 21 Feb 2025
Viewed by 1005
Abstract
Mental illnesses can have a significant impact on individuals experiencing acute coronary syndromes (ACS). Mental illnesses are associated with an increased cardiovascular risk profile and early onset of cardiovascular disease. A critical aspect of this interplay is the effect of psychiatric conditions on [...] Read more.
Mental illnesses can have a significant impact on individuals experiencing acute coronary syndromes (ACS). Mental illnesses are associated with an increased cardiovascular risk profile and early onset of cardiovascular disease. A critical aspect of this interplay is the effect of psychiatric conditions on left ventricular ejection fraction (LVEF), a key parameter in evaluating cardiac function and predicting long-term outcomes in ACS patients. The present single-center, retrospective study investigated the associations between psychiatric conditions and cardiac function, with a focus on LVEF in ACS patients. The inclusion criteria were Italian nationality and 30 years or older. One hundred and sixty-four patients without (Mage = 68.8 ± 10.6, 62 females) and 161 patients with a psychiatric diagnosis (Mage = 68.4 ± 13.7, 63 females) were enrolled. The data collected included sociodemographic variables, psychiatric diagnoses, LVEF, ACS type (STEMI/NSTEMI), smoking status, previous interventions, and pharmacological treatments. Statistical analyses included chi-square, t-tests, ANOVAs, and ANCOVA to assess differences across groups. Findings revealed lower LVEF in patients with a psychiatric diagnosis compared to patients without a psychiatric diagnosis (p = 0.004, d = 0.36). Patients without a psychiatric diagnosis were associated with NSTEMI (p = 0.047, φ = 0.11), hypertension (p = 0.003, φ = −0.16), and dyslipidemia (p = 0.022, φ = −0.13). In contrast, patients with a psychiatric diagnosis were associated with STEMI (p = 0.047, φ = 0.11), neurological dysfunction (p = 0.014, φ = 0.14), and chronic obstructive pulmonary disease (p = 0.010, φ = 0.14). Among psychiatric diagnoses, anxiety disorders were associated with lower LVEF compared to substance abuse disorders (p = 0.012, d = −0.81). The findings underscore the complex relationship between mental illness and cardiac function, emphasising the need to integrate psychiatric evaluations into cardiology care to optimise the management of both mental and cardiovascular health. This study has several limitations, including its design, which prevents causal conclusions, and the use of convenience sampling, which limits the generalizability of the findings. Full article
Show Figures

Figure 1

25 pages, 811 KiB  
Review
Clinical, Research, and Educational Applications of ChatGPT in Dentistry: A Narrative Review
by Francesco Puleio, Giorgio Lo Giudice, Angela Mirea Bellocchio, Ciro Emiliano Boschetti and Roberto Lo Giudice
Appl. Sci. 2024, 14(23), 10802; https://doi.org/10.3390/app142310802 - 21 Nov 2024
Cited by 3 | Viewed by 3308
Abstract
Artificial intelligence (AI), specifically Generative Pre-trained Transformer (GPT) technology, has revolutionized various fields, including medicine and dentistry. The AI model ChatGPT, developed by OpenAI, mimics human language on a large scale, generating coherent and contextually appropriate responses. ChatGPT serves as an auxiliary resource [...] Read more.
Artificial intelligence (AI), specifically Generative Pre-trained Transformer (GPT) technology, has revolutionized various fields, including medicine and dentistry. The AI model ChatGPT, developed by OpenAI, mimics human language on a large scale, generating coherent and contextually appropriate responses. ChatGPT serves as an auxiliary resource for diagnosis and decision-making across various medical disciplines. This comprehensive narrative review aims to explore how ChatGPT can assist the dental sector, highlighting its potential to enhance various aspects of the discipline. This review includes a literature search on the application of ChatGPT in dentistry, with a focus on the differences between the free version, ChatGPT 3.5, and the more advanced subscription-based version, ChatGPT 4. Specifically, ChatGPT has proven to be effective in enhancing user interaction, providing fast and accurate information and improving the accessibility of knowledge. However, despite these advantages, several limitations are identified, including concerns regarding the accuracy of responses in complex scenarios, ethical considerations surrounding its use, and the need for improved training to handle highly specialized queries. In conclusion, while ChatGPT offers numerous benefits in terms of efficiency and scalability, further research and development are needed to address these limitations, particularly in areas requiring greater precision, ethical oversight, and specialized expertise. Full article
(This article belongs to the Special Issue Digital Dentistry and Oral Health)
Show Figures

Figure 1

17 pages, 625 KiB  
Systematic Review
Augmented Reality in Dentistry: Enhancing Precision in Clinical Procedures—A Systematic Review
by Francesco Puleio, Vincenzo Tosco, Rosario Pirri, Michele Simeone, Riccardo Monterubbianesi, Giorgio Lo Giudice and Roberto Lo Giudice
Clin. Pract. 2024, 14(6), 2267-2283; https://doi.org/10.3390/clinpract14060178 - 28 Oct 2024
Cited by 1 | Viewed by 2462
Abstract
Background: Augmented reality (AR) enhances sensory perception by adding extra information, improving anatomical localization and simplifying treatment views. In dentistry, digital planning on bidimensional screens lacks real-time feedback, leading to potential errors. However, it is not clear if AR can improve the clinical [...] Read more.
Background: Augmented reality (AR) enhances sensory perception by adding extra information, improving anatomical localization and simplifying treatment views. In dentistry, digital planning on bidimensional screens lacks real-time feedback, leading to potential errors. However, it is not clear if AR can improve the clinical treatment precision. The aim of this research is to evaluate if the use of AR-based instruments could improve dental procedure precision. Methods: This review covered studies from January 2018 to June 2023, focusing on AR in dentistry. The PICO question was “Does AR increase the precision of dental interventions compared to non-AR techniques?”. The systematic review was carried out on electronic databases, including Ovid MEDLINE, PubMed, and the Web of Science, with the following inclusion criteria: studies comparing the variation in the precision of interventions carried out with AR instruments and non-AR techniques. Results: Thirteen studies were included. Conclusions: The results of this systematic review demonstrate that AR enhances the precision of various dental procedures. The authors advise clinicians to use AR-based tools in order to improve the precision of their therapies. Full article
Show Figures

Figure 1

12 pages, 1585 KiB  
Article
Fibromyalgia and Orofacial Health: Administration of a Dental Disease Assessment Questionnaire
by Francesco Puleio, Giorgio Lo Giudice, Alessandro Molica Colella, Maria Grazia Cannarozzo, Riccardo Polosa, Angela Alibrandi and Roberto Lo Giudice
Appl. Sci. 2024, 14(16), 6908; https://doi.org/10.3390/app14166908 - 7 Aug 2024
Cited by 3 | Viewed by 2014
Abstract
Aim: This study examines the prevalence and severity of orofacial disorders in patients with fibromyalgia syndrome (FMS). The research assesses the correlation with the Fibromyalgia Assessment Status (FAS) index. The goal is to improve the clinical approaches to these patients. Methods: A cross-sectional [...] Read more.
Aim: This study examines the prevalence and severity of orofacial disorders in patients with fibromyalgia syndrome (FMS). The research assesses the correlation with the Fibromyalgia Assessment Status (FAS) index. The goal is to improve the clinical approaches to these patients. Methods: A cross-sectional study was conducted using a structured questionnaire focused on the correlation between FMS and orofacial problems. The research involved 107 rheumatology patients diagnosed with FMS. Statistical analyses, including Spearman’s correlation, were utilized to investigate the relationships between the FAS index scores and various orofacial symptoms. Results: Of the participants, 11.2% responded that they were aware of the correlation between fibromyalgia and oral health. The statistical analysis showed statistically significant correlations between the FAS index and symptoms such as gum bleeding, teeth grinding during the day, and neck pain (p < 0.05). The correlation between the FAS index and joint noise upon opening the mouth, as well as dissatisfaction with one’s smile, also proved to be highly significant (p < 0.001). Conclusion: The outcomes demonstrate that, as the FAS index increases, the likelihood of developing orofacial disorders also increases among FMS patients. This highlights the importance of a multidisciplinary treatment approach. Full article
(This article belongs to the Special Issue Orofacial Pain: Diagnosis and Treatment)
Show Figures

Figure 1

12 pages, 975 KiB  
Article
CYP7B1 as a Biomarker for Prostate Cancer Risk and Progression: Metabolic and Oncogenic Signatures (Diagnostic Immunohistochemistry Analysis by Tissue Microarray in Prostate Cancer Patients—Diamond Study)
by Giorgio Ivan Russo, Emil Durukan, Maria Giovanna Asmundo, Arturo Lo Giudice, Serena Salzano, Sebastiano Cimino, Antonio Rescifina, Mikkel Fode, Ali Saber Abdelhameed, Rosario Caltabiano and Giuseppe Broggi
Int. J. Mol. Sci. 2024, 25(9), 4762; https://doi.org/10.3390/ijms25094762 - 27 Apr 2024
Viewed by 1469
Abstract
We aimed to analyze the association between CYP7B1 and prostate cancer, along with its association with proteins involved in cancer and metabolic processes. A retrospective analysis was performed on 390 patients with prostate cancer (PC) or benign prostatic hyperplasia (BPH). We investigated the [...] Read more.
We aimed to analyze the association between CYP7B1 and prostate cancer, along with its association with proteins involved in cancer and metabolic processes. A retrospective analysis was performed on 390 patients with prostate cancer (PC) or benign prostatic hyperplasia (BPH). We investigated the interactions between CYP7B1 expression and proteins associated with PC and metabolic processes, followed by an analysis of the risk of biochemical recurrence based on CYP7B1 expression. Of the 139 patients with elevated CYP7B1 expression, 92.8% had prostate cancer. Overall, no increased risk of biochemical recurrence was associated with CYP7B1 expression. However, in a non-diabetic subgroup analysis, higher CYP7B1 expression indicated a higher risk of biochemical recurrence, with an HR of 1.78 (CI: 1.0–3.2, p = 0.05). PC is associated with elevated CYP7B1 expression. In a subgroup analysis of non-diabetic patients, elevated CYP7B1 expression was associated with an increased risk of biochemical recurrence, suggesting increased cancer aggressiveness. Full article
(This article belongs to the Section Molecular Informatics)
Show Figures

Figure 1

11 pages, 3504 KiB  
Case Report
Customized Facial Orthopedics: Proof of Concept for Generating 3D-Printed Extra-Oral Appliance for Early Intervention in Class III Malocclusion
by Vincenzo Ronsivalle, Giorgio Gastaldi, Gianluigi Fiorillo, Alessandra Amato, Carla Loreto, Rosalia Leonardi and Antonino Lo Giudice
Prosthesis 2024, 6(1), 135-145; https://doi.org/10.3390/prosthesis6010011 - 1 Feb 2024
Cited by 3 | Viewed by 1466
Abstract
Background: The present case report serves as a proof of concept for the fabrication and effective clinical administration of a 3D-printed chin cup tailored to the patient’s anatomical characteristics. Methods: An 11-year-old male with a Class III malocclusion was treated using a chin [...] Read more.
Background: The present case report serves as a proof of concept for the fabrication and effective clinical administration of a 3D-printed chin cup tailored to the patient’s anatomical characteristics. Methods: An 11-year-old male with a Class III malocclusion was treated using a chin cup appliance to intercept and control a Class III mandibular skeletal growing pattern early. Two tailored chin cup devices were designed using 3D face scanning and CBCT scanning and were produced with additive manufacturing techniques. The chin pads were digitally designed based on a 3D scan of the patient’s face. The 3D modeling of chin cup components was performed using 3Shape Appliance Designer and 3D printed with biocompatible resin. An analogic chin pad was also produced for the same patient. The treatment plan involved the patient wearing the chin cup for 13 h per day. The patient was instructed to use all three chin pads produced at intervals of 4 months. The patient’s experience was assessed by reporting the comfort experience via a VAS scale. The treatment strategy was effective in improving the skeletal Class III malocclusion. Additionally, the integration of 3D face scanning (or CBCT scanning), modeling, and printing enables the production of customized chin cups with superior fit and comfort, contributing to enhanced patient compliance and treatment efficacy. Full article
(This article belongs to the Special Issue Digital Technologies, Materials and Telemedicine in Dentistry)
Show Figures

Figure 1

13 pages, 318 KiB  
Article
Prostate Cancer Severity in Relation to Level of Food Processing
by Salvatore Sciacca, Arturo Lo Giudice, Maria Giovanna Asmundo, Sebastiano Cimino, Ali A. Alshatwi, Giuseppe Morgia, Matteo Ferro and Giorgio Ivan Russo
Nutrients 2023, 15(18), 4010; https://doi.org/10.3390/nu15184010 - 16 Sep 2023
Cited by 2 | Viewed by 1946
Abstract
Background: The level of food processing has gained interest as a potential determinant of human health. The aim of this study was to assess the relationship between the level of food processing and prostate cancer severity. Methods: A sample of 120 consecutive patients [...] Read more.
Background: The level of food processing has gained interest as a potential determinant of human health. The aim of this study was to assess the relationship between the level of food processing and prostate cancer severity. Methods: A sample of 120 consecutive patients were examined for the following: their dietary habits, assessed through validated food frequency questionnaires; their dietary intake of food groups, categorized according to the NOVA classification; and their severity of prostate cancer, categorized into risk groups according to European Association of Urology (EAU) guidelines. Uni- and multivariate logistic regression analyses were performed to test the association between the variables of interest. Results: Individuals reporting a higher consumption of unprocessed/minimally processed foods were less likely to have greater prostate cancer severity than those who consumed less of them in the energy-adjusted model (odds ratio (OR) = 0.38, 95% confidence interval (CI): 1.17–0.84, p = 0.017 and OR = 0.33, 95% CI: 0.12–0.91, p = 0.032 for medium/high vs. low grade and high vs. medium/low grade prostate cancers, respectively); however, after adjusting for potential confounding factors, the association was not significant anymore. A borderline association was also found between a higher consumption of ultra-processed foods and greater prostate cancer severity in the energy-adjusted model (OR = 2.11, 95% CI: 0.998–4.44; p = 0.051), but again the association was not significant anymore after adjusting for the other covariates. Conclusions: The level of food processing seems not to be independently associated with prostate cancer severity, while potentially related to other factors that need further investigation. Full article
(This article belongs to the Section Nutrition and Public Health)
12 pages, 620 KiB  
Review
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
by Octavian Sabin Tataru, Michele Marchioni, Felice Crocetto, Biagio Barone, Giuseppe Lucarelli, Francesco Del Giudice, Gian Maria Busetto, Alessandro Veccia, Arturo Lo Giudice, Giorgio Ivan Russo, Stefano Luzzago, Mattia Luca Piccinelli, Mihai Dorin Vartolomei, Gennaro Musi and Matteo Ferro
Diagnostics 2023, 13(4), 593; https://doi.org/10.3390/diagnostics13040593 - 6 Feb 2023
Cited by 29 | Viewed by 3727
Abstract
Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is under development and will add more value in limiting the postoperative renal function loss and morbidity. We aimed to comprehensively review the research on single photon emission computed tomography/computed tomography (SPECT/CT) and [...] Read more.
Novel molecular imaging opportunities to preoperatively diagnose renal cell carcinoma is under development and will add more value in limiting the postoperative renal function loss and morbidity. We aimed to comprehensively review the research on single photon emission computed tomography/computed tomography (SPECT/CT) and positron emission tomography computed tomography (PET-CT) molecular imaging and to enhance the urologists’ and radiologists’ knowledge of the current research pattern. We identified an increase in prospective and also retrospective studies that researched to distinguish between benign and malignant lesions and between different clear cell renal cell carcinoma subtypes, with small numbers of patients studied, nonetheless with excellent results on specificity, sensitivity and accuracy, especially for 99mTc-sestamibi SPECT/CT that delivers quick results compared to a long acquisition time for girentuximab PET-CT, which instead gives better image quality. Nuclear medicine has helped clinicians in evaluating primary and secondary lesions, and has lately returned with new and exciting insights with novel radiotracers to reinforce its diagnostic potential in renal carcinoma. To further limit the renal function loss and post-surgery morbidity, future research is mandatory to validate the results and to clinically implement the diagnostic techniques in the context of precision medicine. Full article
(This article belongs to the Special Issue Future Trends in Radioisotope-Based Imaging 2.0)
Show Figures

Figure 1

10 pages, 429 KiB  
Article
Is There a Role of Warburg Effect in Prostate Cancer Aggressiveness? Analysis of Expression of Enzymes of Lipidic Metabolism by Immunohistochemistry in Prostate Cancer Patients (DIAMOND Study)
by Giorgio Ivan Russo, Maria Giovanna Asmundo, Arturo Lo Giudice, Giuseppe Trefiletti, Sebastiano Cimino, Matteo Ferro, Riccardo Lombardo, Cosimo De Nunzio, Giuseppe Morgia, Eliana Piombino, Maria Failla, Rosario Caltabiano and Giuseppe Broggi
Cancers 2023, 15(3), 948; https://doi.org/10.3390/cancers15030948 - 2 Feb 2023
Cited by 8 | Viewed by 2378
Abstract
Prostate Cancer (PCa) is still ranked as the first cancer in the male population and evidences have suggested an alteration of glycemic and lipidic metabolism that are related to its progression and prognosis. The aim of the study is to investigate associations between [...] Read more.
Prostate Cancer (PCa) is still ranked as the first cancer in the male population and evidences have suggested an alteration of glycemic and lipidic metabolism that are related to its progression and prognosis. The aim of the study is to investigate associations between enzymes’ expression, especially involved in the lipidic pathway, and PCa aggressiveness. We retrospectively analyzed data from 390 patients with PCa or benign prostatic hyperplasia (BPH) at the Department of Urology, University of Catania. Immunohistochemical slides were evaluated for the expression of proteins related to glucose and lipidic metabolism. A total of 286 were affected by PCa while 104 by BPH. We demonstrated that ATP-lyase (odds ratio [OR]: 1.71; p < 0.01), fatty acid synthase (OR: 4.82; p < 0.01), carnitine palmitoyl transferase-1a (OR: 2.27; p < 0.05) were associated with androgen receptor (AR) expression. We found that steaoryl Co-A desaturase expression in PCa patients with total cholesterol ≥ 200 mg/dL was independently associated with ISUP ≥4 (OR: 4.22; p = 0.049). We found that CPT-1a+ was associated with biochemical recurrence (hazard ratio: 1.94; p = 0.03]). Our results support the evidence that the manipulation of lipidic metabolism could serve in the future to contrast PCa progression. Full article
(This article belongs to the Special Issue Lifestyle Modifications and Survival of Cancer Patients)
Show Figures

Figure 1

15 pages, 3069 KiB  
Article
Genomic Landscape Alterations in Primary Tumor and Matched Lymph Node Metastasis in Hormone-Naïve Prostate Cancer Patients
by Giorgio Ivan Russo, Paolo Bonacci, Dalida Bivona, Grete Francesca Privitera, Giuseppe Broggi, Rosario Caltabiano, Jessica Vella, Arturo Lo Giudice, Maria Giovanna Asmundo, Sebastiano Cimino, Giuseppe Morgia, Stefania Stefani and Nicolò Musso
Cancers 2022, 14(17), 4212; https://doi.org/10.3390/cancers14174212 - 30 Aug 2022
Cited by 8 | Viewed by 2272
Abstract
Background: Prostate cancer (PCa) is a disease with a wide range of clinical manifestations. Up to the present date, the genetic understanding of patients with favorable or unfavorable prognosis is gaining interest for giving the appropriate tailored treatment. We aimed to investigate genetic [...] Read more.
Background: Prostate cancer (PCa) is a disease with a wide range of clinical manifestations. Up to the present date, the genetic understanding of patients with favorable or unfavorable prognosis is gaining interest for giving the appropriate tailored treatment. We aimed to investigate genetic changes associated with lymph node metastasis in a cohort of hormone-naïve Pca patients. Methods: We retrospectively analyzed data from 470 patients who underwent surgery for PCa between 2010 and 2020 at the Department of Urology, University of Catania. Inclusion criteria were patients with lymph node metastasis and patients with PCa with extra capsular extension (pT3) and negative lymph node metastasis. The final cohort consisted of 17 different patients (11 PCa with lymph node metastasis and 6 PCa without lymph node metastasis). Through the cBioPortal online tool, we analyzed gene alterations and their correlations with clinical factors. Results: A total of 688 intronic, synonym and nonsynonym mutations were sequenced. The gene with the most sequenced mutations was ERBB4 (83 mutations, 12% of 688 total), while the ones with the lower percentage of mutations were AKT1, FGFR2 and MLH1 (1 mutation alone, 0.14%). Conclusion: In the present study we found mostly concordance concerning the ERBB4 mutation between both primary PCa samples and matched lymph node metastasis, underlining that the identification of alterations in the primary tumor is extremely important for cancer prognosis prediction. Full article
Show Figures

Figure 1

6 pages, 215 KiB  
Editorial
Impact of the COVID-19 Pandemic on Global Diseases and Human Well-Being
by Arturo Lo Giudice, Maria Giovanna Asmundo, Sebastiano Cimino and Giorgio Ivan Russo
J. Clin. Med. 2022, 11(15), 4489; https://doi.org/10.3390/jcm11154489 - 1 Aug 2022
Cited by 1 | Viewed by 1517
Abstract
This editorial of the Special Issue “Impact of SARS-CoV-2 Pandemic on Global Diseases and Human Well-Being” aims to portray the repercussions of the novel COVID-19 emergency on a wide range of health issues [...] Full article
(This article belongs to the Special Issue Impact of COVID-19 Pandemic on Global Diseases and Human Well-Being)
10 pages, 2888 KiB  
Case Report
Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review
by Marianna Caterino, Mario Pirozzi, Sergio Facchini, Alessia Zotta, Antonello Sica, Giorgio Lo Giudice, Raffaele Rauso, Elisa Varriale, Fortunato Ciardiello and Morena Fasano
Medicina 2022, 58(5), 666; https://doi.org/10.3390/medicina58050666 - 17 May 2022
Cited by 5 | Viewed by 3999
Abstract
Differentiated thyroid cancer (DTC) includes papillary and follicular carcinomas and is the most common type of thyroid cancer. The incidence of this cancer has increased in the last few years, and even if its prognosis is generally good for a subset of patients [...] Read more.
Differentiated thyroid cancer (DTC) includes papillary and follicular carcinomas and is the most common type of thyroid cancer. The incidence of this cancer has increased in the last few years, and even if its prognosis is generally good for a subset of patients that does not respond to radioactive iodine (RAI) therapy, the prognosis is much worse: the median overall survival (OS) from discovery of metastasis is 3–5 years and the 10-year survival rate is only 10%. Several mutations, including RAS or RET, as well as BRAF signaling, are associated with thyroid cancer. Liquid biopsy may be useful in selected patient to identify genomic alterations and thus allowing for a precision medicine approach with target therapy. Sorafenib, an oral multi-kinase inhibitor, can be used in the treatment of DTC. Case presentation: A 77 years old. man with diagnosis of metastatic DTC and evidence of presence of mutation of BRAF K601E on liquid biopsy was treated with sorafenib, showing a good response to the treatment and an improvement in the quality of life (QoL). Currently, this patient is still on treatment with sorafenib, gaining control of a multi-metastatic disease, generally characterized by a very poor prognosis. In conclusion, sorafenib has an active role in the treatment of DTC. It also has been considered the standard of care for patients with advanced unresectable hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). In our case we observe the efficacy of using sorafenib in Papillary thyroid carcinoma (PTC) such as confirming both stable disease (SD) in the CT scan as clinical benefit with an increase in QoL. Therefore, use of sorafenib remains an important treatment option, even in case of BRAF mutation, despite a rapidly evolving treatment landscape. It also seems important to perform liquid biopsies, especially in patients in whom it is not possible to repeat a new tissue biopsy. Ongoing clinical trials continue to evaluate sorafenib in different settings, and in combination with other therapies in DTC and HCC. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

12 pages, 2674 KiB  
Article
Kabat Rehabilitation in Facial Nerve Palsy after Parotid Gland Tumor Surgery: A Case-Control Study
by Ciro Emiliano Boschetti, Giorgio Lo Giudice, Chiara Spuntarelli, Carmine Apice, Raffaele Rauso, Mario Santagata, Gianpaolo Tartaro and Giuseppe Colella
Diagnostics 2022, 12(3), 565; https://doi.org/10.3390/diagnostics12030565 - 23 Feb 2022
Cited by 14 | Viewed by 7737
Abstract
Temporary facial nerve palsy after parotid tumor surgery ranges from 14 to 65%, depending on surgery, tumor type, and subsite. The study aimed to evaluate the role of Kabat physical rehabilitation in the outcomes of patients affected by severe facial nerve palsy following [...] Read more.
Temporary facial nerve palsy after parotid tumor surgery ranges from 14 to 65%, depending on surgery, tumor type, and subsite. The study aimed to evaluate the role of Kabat physical rehabilitation in the outcomes of patients affected by severe facial nerve palsy following parotid gland surgery. The results and clinical data of two groups, Kabat and non-Kabat (control), were statistically compared. Descriptive statistics, the multiple linear regression model, difference in difference approach, and the generalized linear model were used. F-Test, Chi-square test, McFadden R-squared, and adjusted R-squared were used to assess the significance. The results showed that the House–Brackmann (HB) stage of patients who had physiotherapy performed were lower than the control group. The decrease of HB staging in the Kabat group at 3 months was −0.71 on average, thus the probability of having a high HB stage decreased by about 13% using Kabat therapy. The results are statistically significant, and indicated that when the Kabat rehabilitation protocol is performed, mainly in the cases of a high-grade HB score, the patients showed a better and faster improvement in postoperative facial nerve palsy. Full article
(This article belongs to the Special Issue Evidence-Based Diagnosis and Management of Facial Nerve Disorders)
Show Figures

Figure 1

14 pages, 2695 KiB  
Review
The Clinical Role of SRSF1 Expression in Cancer: A Review of the Current Literature
by Arturo Lo Giudice, Maria Giovanna Asmundo, Giuseppe Broggi, Sebastiano Cimino, Giuseppe Morgia, Ettore Di Trapani, Stefano Luzzago, Gennaro Musi, Matteo Ferro, Ottavio de Cobelli and Giorgio I. Russo
Appl. Sci. 2022, 12(5), 2268; https://doi.org/10.3390/app12052268 - 22 Feb 2022
Cited by 9 | Viewed by 5784
Abstract
Background: SFRS1 is a member of the splicing factor protein family. Through a specific sequence of alteration, SRSF1 can move from the cytoplasm to the nucleus where it can work autonomously as a splicing activator, or as a silencer when interacting with [...] Read more.
Background: SFRS1 is a member of the splicing factor protein family. Through a specific sequence of alteration, SRSF1 can move from the cytoplasm to the nucleus where it can work autonomously as a splicing activator, or as a silencer when interacting with other regulators. Alternative splicing (AS) is a fundamental biological process that ensures protein diversity. In fact, different proteins, produced by alternative splicing, can gain different and even antagonistic biological functions. Methods: Our review is based on English articles published in the MEDLINE/PubMed medical library between 2000 and 2021. We retrieved articles that were specifically related to SRSF1 and cancers, and we excluded other reviews and meta-analyses. We included in vitro studies, animal studies and clinical studies, evaluated using the Medical Education Research Study Quality Instrument (MERSQI) and the Newcastle–Ottawa Scale-Education (NOSE). Result: SRSF1 is related to various genes and plays a role in cell cycle, ubiquitin-mediated proteolysis, nucleotide excision repair, p53 pathway, apoptosis, DNA replication and RNA degradation. In most cases, SRSF1 carries out its cancer-related function via abnormal alternative splicing (AS). However, according to the most recent literature, SRSF1 may also be involved in mRNA translation and cancer chemoresistance or radio-sensitivity. Conclusion: Our results showed that SRSF1 plays a key clinical role in tumorigenesis and tumor progression in several types of cancer (such as Prostate, Lung, Breast, Colon, Glioblastoma), through various mechanisms of action and different cellular pathways. This review could be a starting point for several studies regarding the biology of and therapies for cancer. Full article
(This article belongs to the Special Issue Immunohistochemical Expression Volume II)
Show Figures

Figure 1

9 pages, 228 KiB  
Article
Salivary Gland Disorders in Pediatric Patients: A 20 Years’ Experience
by Giorgio Lo Giudice, Paola Martina Marra, Chiara Colella, Angelo Itro, Gianpaolo Tartaro and Giuseppe Colella
Appl. Sci. 2022, 12(4), 1999; https://doi.org/10.3390/app12041999 - 14 Feb 2022
Cited by 4 | Viewed by 2955
Abstract
Salivary gland disorders are uncommon in children; they show a lower prevalence when compared to adults. The literature has a relative lack of information about the management and the different treatment protocols regarding these diseases. The aim of this research is to investigate [...] Read more.
Salivary gland disorders are uncommon in children; they show a lower prevalence when compared to adults. The literature has a relative lack of information about the management and the different treatment protocols regarding these diseases. The aim of this research is to investigate the prevalence of both benign and malignant salivary gland disorders, focusing on diagnostic and therapy. An audit of patients diagnosed with salivary gland disorders was conducted from 2000 to 2020. 99 patients’ records were selected and analyzed: 51 males’ and 48 females’, age 10 ± 4 SD. Obstructive pathologies were the most frequently diagnosed (49 patients) followed by oncologic (21 patients), inflammatory (20 patients), rheumatologic (4 patients), malformative (3 patients) and infective disorders (2 patients). The parotid was the most affected major gland in 47 cases with a prevalence of diagnosis of juvenile recurrent parotitis (JRP) (40.4%), followed by the sublingual gland in 14 cases of ranula (100%) and the submandibular gland in 11 patients suffering from sialolithiasis (84.6%). Swelling was the most common symptom (75.7% of patients). Seven different neoplasms were documented. A greater prevalence of low-grade mucoepidermoid carcinoma among the malignant group (38.1% of oncologic cases) was noted. In regards to benign tumors, pleomorphic adenoma was the most common diagnosis (47.6% of cases). The symptoms and outcomes showed statistical significance concerning gender. Although salivary gland diseases in children and adolescents are rare, it is essential to observe and monitor all of the symptoms to intervene if necessary, as painless swelling is a symptom common from both benign and malignant diseases. Full article
(This article belongs to the Special Issue Oral Pathology and Medicine: Diagnosis and Therapy)
Back to TopTop